Cho Ki-Ho, Kim Young-Suk, Jung Woo-Sang, Kim Tae-Hun
Department of Cardiovascular and Neurologic Diseases, College of Oriental Medicine, Graduate School, Kyung Hee University, Seoul, Korea.
J Acupunct Meridian Stud. 2011 Jun;4(2):129-33. doi: 10.1016/S2005-2901(11)60019-8.
Hot flashes are one of the main problems in postmenopausal patients. Hormone replacement therapy is the standard treatment for this vasomotor symptom, but long-term estrogen treatment can produce serious adverse effects such as higher risks of cardiovascular disease and breast cancer. For this reason, hormone replacement therapy may not be advisable for young patients. Gui-zhi-fu-ling-wan is an herbal decoction for hot flashes used in traditional Chinese medicine. We have extensive experience treating hot flashes in young women; this preliminary case series evaluates the effectiveness of Gui-zhi-fu-ling-wan for alleviating hot flashes in young patients. In this retrospective case series, we reviewed the medical records of outpatients who visited the Department of Cardiovascular and Neurologic Disease, Kyung Hee Oriental Medical Center for hot flashes from October 1, 2003 to October 1, 2008. Of the 60 cases, 37 met the inclusion criteria. Mean improvement in symptoms, as assessed using the visual analog scale, was 40.4 ± 28.5%; 51.3% of patients experienced a 50% improvement. According to the secondary analysis, the results of differential diagnosis of cold and hot syndrome and blood stasis syndrome did not affect scores. Only 2.7% of the patients reported adverse events. Our findings suggest that Gui-zhi-fu-ling-wan improves hot flashes in young patients in a relatively safe manner. However, rigorous clinical studies are needed to confirm these results.
潮热是绝经后患者的主要问题之一。激素替代疗法是这种血管舒缩症状的标准治疗方法,但长期雌激素治疗会产生严重的不良反应,如心血管疾病和乳腺癌风险增加。因此,激素替代疗法可能不适用于年轻患者。桂枝茯苓丸是一种用于治疗潮热的中药汤剂。我们在治疗年轻女性潮热方面有丰富经验;这个初步的病例系列评估了桂枝茯苓丸缓解年轻患者潮热的有效性。在这个回顾性病例系列中,我们回顾了2003年10月1日至2008年10月1日期间到庆熙东方医学中心心血管和神经疾病科就诊的门诊患者中因潮热就诊的病历。60例患者中,37例符合纳入标准。使用视觉模拟量表评估,症状的平均改善率为40.4±28.5%;51.3%的患者症状改善了50%。根据二次分析,寒热证和血瘀证的鉴别诊断结果不影响评分。只有2.7%的患者报告了不良事件。我们的研究结果表明,桂枝茯苓丸能以相对安全的方式改善年轻患者的潮热。然而,需要进行严格的临床研究来证实这些结果。